Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pembrolizumab plus chemotherapy, olaparib and bevacizumab versus chemotherapy plus bevacizumab in women (Japan, Phase 3)
jRCT2080224550Phase 3Completed
- Start
- Feb 2019
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised trial of pembrolizumab (2 arms). Started Feb 2019; status: completed.
02
Drugs
Beyond the preview
Go deeper on jRCT2080224550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224550.